These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 9477186
1. Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase. Akimoto S, Furuya Y, Akakura K, Shimazaki J, Ito H. Int J Urol; 1997 Nov; 4(6):572-5. PubMed ID: 9477186 [Abstract] [Full Text] [Related]
8. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis. Kamiya N, Suzuki H, Yano M, Endo T, Takano M, Komaru A, Kawamura K, Sekita N, Imamoto T, Ichikawa T. Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975 [Abstract] [Full Text] [Related]
9. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer]. Wang ZL, Wang XF. Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960 [Abstract] [Full Text] [Related]
11. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer. Akimoto S, Akakura K, Shimazaki J. Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556 [Abstract] [Full Text] [Related]
15. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group]. Taue R, Kanayama H, Kagawa S. Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358 [Abstract] [Full Text] [Related]